Rh41-MAB391R (Q54950360)

From Wikidata

Jump to navigation Jump to search

cell line

Language	Label	Description	Also known as
English	Rh41-MAB391R	cell line

Statements

1 reference

Cellosaurus release 44

27 January 2023

cancer cell line

1 reference

Cellosaurus release 44

27 January 2023

parent cell line

1 reference

Cellosaurus release 44

27 January 2023

described by source

Differential mechanisms of acquired resistance to insulin-like growth factor-i receptor antibody therapy or to a small-molecule inhibitor, BMS-754807, in a human rhabdomyosarcoma model

1 reference

Cellosaurus release 44

27 January 2023

established from medical condition

alveolar rhabdomyosarcoma

1 reference

Cellosaurus release 44

27 January 2023

derived from organism type

1 reference

Cellosaurus release 44

27 January 2023

Identifiers

1 reference

Cellosaurus release 44

27 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54950360&oldid=1861725918"